Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Immunochromatogenic Test Detects H. Pylori in Fecal Samples

By LabMedica International staff writers
Posted on 01 Feb 2012
A rapid visual assay has been developed for the detection of Helicobacter pylori in fecal samples.

Called Pyloritop Ag+, the assay is an immunochromatogenic test that provides clinical laboratories with a cost-effective method to help meet current guidelines for the detection and treatment of H. More...
pylori.

Pyloritop Ag+ provides a quick, convenient, and noninvasive means for detecting H. pylori infection. Results are available in five minutes and should help clinicians avoid unnecessary, costly, and perhaps harmful treatments.

Released by Pro-Lab Diagnostics (Bromborough, United Kingdom), the new assay is based on robust lateral flow technology. Individually wrapped Pyloritop Ag+ test cassettes are supplied with a sample collection tube for maximum convenience, and can be safely stored at room temperature for up to 12 months, providing a practical solution for H. pylori testing.

Infection with H. pylori is estimated to affect 40%-50 % of the population, and can have a significant impact on the treatment of patients with gastroduodenal diseases, gastric cancers, and unexplained iron deficiency anemia.

Mark Reed, general manager of Pro-Lab Diagnostics, commented: “Pyloritop Ag+ is the latest addition to Pro-Lab Diagnostics’ portfolio of immunodiagnostic products [….]. This simple test offers clear, qualitative results in just a few minutes, helping to streamline laboratory workflows for better patient care.”

Related Links:

Pro-Lab Diagnostics




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.